Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

NCT00121420 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis
Brain Neoplasms

Interventions

DRUG: Motexafin gadolinium

Sponsor

Pharmacyclics LLC.